Shockwave Medical Bolsters Position in Growing IVL Market

Shockwave Medical (owned by Johnson & Johnson) is working to solidify its leadership in the intravascular lithotripsy (IVL) space by focusing on ongoing innovation and clinical data generation, as more medtech companies consider entering the field.

Details

According to a report by Medical Device Network, Shockwave Medical plans to maintain its competitive edge by developing new products and collecting clinical data that demonstrate the effectiveness of its technology. This strategy comes as a growing number of companies seek to enter the IVL market, intensifying competition.

Context

The IVL sector is one of the fastest-growing segments in medtech, used to treat arterial calcifications. Johnson & Johnson acquired Shockwave Medical in a major deal, bolstering its ability to compete.

What This Means for Investors

These developments indicate that Shockwave Medical is leveraging innovation and data as key tools to stay ahead. The success of this strategy could impact its market share and valuation, especially as new competitors emerge.